Odevixibat as an adjunctive treatment for refractory pruritus in rare variants of cholestatic liver...
Odevixibat as an adjunctive treatment for refractory pruritus in rare variants of cholestatic liver disease
About this item
Full title
Author / Creator
Publisher
United States: John Wiley and Sons Inc
Journal title
Language
English
Formats
Publication information
Publisher
United States: John Wiley and Sons Inc
Subjects
More information
Scope and Contents
Contents
Objectives
Odevixibat, a reversible ileal bile acid transport inhibitor, has been shown to reduce serum bile acids (sBA) and pruritus mostly in children with progressive familial intrahepatic cholestasis (PFIC) 1 and 2 in clinical trials and case reports. There are currently no published case reports or series describing its use in rare variants...
Alternative Titles
Full title
Odevixibat as an adjunctive treatment for refractory pruritus in rare variants of cholestatic liver disease
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11322002
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11322002
Other Identifiers
ISSN
2691-171X
E-ISSN
2691-171X
DOI
10.1002/jpr3.12069
